Study of risk factors associated with peripheral arteriopathy in Japanese-Brazilians from Bauru (SP)

Luciana Garofolo1, Sandra Roberta G Ferreira2, Fausto Miranda Junior3

  • 1Universidade Federal de Sao Paulo, Sao Paulo, SP, Brasil.

Insights

Peripheral arterial disease (PAD) affects 21.1% of Japanese-Brazilians, linked to smoking and hypertension. This highlights the need for targeted cardiovascular disease prevention in at-risk populations.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Vascular Health

Background:

  • Cardiovascular diseases are a leading cause of death globally, with atherosclerosis as a primary driver.
  • Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis, impacting coronary health.
  • Understanding PAD prevalence and risk factors is crucial for managing complications and healthcare costs.

Purpose of the Study:

  • To determine the prevalence of PAD in a Japanese-Brazilian population in Bauru, São Paulo.
  • To investigate the association between PAD and metabolic risk biomarkers in this demographic.
  • To assess the impact of high metabolic disorder prevalence (hypertension, diabetes, hypercholesterolemia) on PAD.

Main Methods:

  • A cross-sectional population study involving 1,038 Japanese-Brazilians aged 30 and above.
  • Evaluations included physical examinations, anthropometric measurements, laboratory tests, and ankle-brachial index (ABI) assessment.
  • PAD was diagnosed with an ABI ≤ 0.90; Poisson regression analyzed associations with risk factors.

Main Results:

  • The prevalence of PAD was 21.1% in the study population, with no significant gender difference.
  • PAD showed a significant association with current smoking (Prevalence Ratio [PR] 2.16) and hypertension (PR 1.56).
  • Other classical risk factors were not independently associated with PAD in this cohort.

Conclusions:

  • The PAD prevalence in Japanese-Brazilians is comparable to other populations with high cardiometabolic risk.
  • Smoking and hypertension are independently associated with PAD in this group.
  • The specific metabolic profile of this population may influence the observed associations with PAD risk factors.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
1.4K
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
2.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886